• Tioconazole in Antifungal Drug Development: Workflows & Insi

  2026-06-11

  Leverage Tioconazole's potent ergosterol pathway inhibition and proven assay reproducibility to streamline antifungal research. This guide details optimized experimental protocols, novel use-cases, and troubleshooting strategies—drawing from APExBIO’s validated solutions and the latest mechanistic breakthroughs.

• CHIR-99021 (CT99021): Advancing Intestinal Organoid Maturati

  2026-06-11

  Explore how CHIR-99021 (CT99021) redefines stem cell biology by enabling advanced intestinal organoid models. This in-depth article reveals unique mechanistic insights, protocol parameters, and translational considerations for GSK-3 inhibition in organoid platforms.

• CXCR4-Targeted Imaging and Therapy in Lymphoma: Theranostic

  2026-06-10

  The reference review synthesizes recent advances in CXCR4-targeted imaging and therapeutic strategies for lymphoma, emphasizing how CXCR4 overexpression drives tumor persistence and therapy resistance. It highlights the clinical promise and technical challenges of integrating molecular imaging with CXCR4 antagonism for precision diagnosis and treatment.

• Quizartinib (AC220): Optimizing FLT3 Inhibition for AML Rese

  2026-06-10

  Quizartinib (AC220) delivers precise, nanomolar-level FLT3 inhibition, enabling robust dissection of acute myeloid leukemia (AML) signaling and resistance. This guide offers detailed workflows, protocol parameters, and troubleshooting strategies to streamline both in vitro and in vivo applications, maximizing reproducibility and data clarity for advanced AML research.

• PPP1R3G/PP1γ Dephosphorylation of RIPK1 Drives Apoptosis and

  2026-06-09

  This study identifies PPP1R3G and PP1γ as essential regulators of RIPK1-dependent apoptosis and type I necroptosis by mediating RIPK1 dephosphorylation. These findings clarify upstream control of cell death decisions and provide new mechanistic insight for dissecting inflammatory and cell death pathways in disease models.

• CHIR-99021 (CT99021): Unlocking 3D Organoid Development via

  2026-06-09

  Explore how CHIR-99021 (CT99021) revolutionizes embryonic stem cell pluripotency and 3D organoid modeling through precise GSK-3 inhibition. Gain advanced insights into spatial cell fate control and practical experimental strategies beyond conventional protocols.

• PP 1 Src Family Tyrosine Kinase Inhibitor: Optimized Workflo

  2026-06-08

  PP 1 offers nanomolar precision for dissecting Src kinase signaling in cancer and immunology research. This article details robust experimental workflows, troubleshooting tips, and the translational impact of selective Src inhibition, anchored by recent mechanistic breakthroughs in metastatic prostate cancer.

• RNASEH1-AS1 as Prognostic lncRNA and Target in Hepatocellula

  2026-06-08

  This article examines a comprehensive analysis of RNASEH1-AS1, a long non-coding RNA newly implicated as a prognostic biomarker and oncogenic target in hepatocellular carcinoma (HCC). The study integrates bioinformatic and experimental approaches to characterize RNASEH1-AS1 expression, associated gene networks, and its mechanistic impact, offering insight for future diagnostic and therapeutic strategies.

• Ibrexafungerp (MK 3118): Overcoming Echinocandin Resistance

  2026-06-07

  Explore how Ibrexafungerp (MK 3118) redefines antifungal research by targeting resistant Candida strains through a novel mechanism. This article delivers advanced insights for labs tackling in vitro and in vivo challenges.

• MDL 28170, Calpain and Cathepsin B Inhibitor: Lab-Validated

  2026-06-06

  This article guides biomedical researchers through practical challenges in cell viability and neuroprotection assays, using evidence-based scenarios to demonstrate the advantages of MDL 28170, Calpain and Cathepsin B Inhibitor, Selective (SKU A4412). Detailed protocol advice, comparative vendor analysis, and literature-backed data position this inhibitor as a robust, reproducible tool for advanced cysteine protease studies.

• GSK621: AMPK Agonist Solutions for AML and Metabolic Researc

  2026-06-05

  GSK621 is a potent AMPK agonist tailored for acute myeloid leukemia and immunometabolic research, offering superior substrate activation and in vivo efficacy. This article provides actionable workflows, troubleshooting strategies, and insights for maximizing assay reliability using APExBIO’s GSK621.

• Sulfamonomethoxine: Mechanistic Clarity & Translational Fron

  2026-06-05

  This thought-leadership piece synthesizes the mechanistic, experimental, and translational dimensions of Sulfamonomethoxine (SMM), offering actionable insights and forward-looking guidance for researchers working at the interface of antimicrobial development, veterinary medicine, and environmental safety. By integrating evidence from recent degradation studies and practical protocol parameters, the article positions APExBIO's SMM as a uniquely validated tool for modern translational science—while also highlighting emerging challenges and opportunities in antimicrobial stewardship.

• Palmitic acid (Hexadecanoic Acid): Technical Use and Protoco

  2026-06-04

  Palmitic acid (SKU N2456) offers a high-purity, well-characterized saturated long-chain fatty acid for in vitro research on lipid metabolism, protein palmitoylation, and metabolic disorders. It is not suitable for workflows requiring aqueous solubility or long-term solution stability. Researchers should follow precise reconstitution and storage protocols to ensure experimental consistency.

• Optimized GBA1-mRNA Restores Lysosomal Function in Gaucher M

  2026-06-04

  The referenced study presents a rationally engineered human GBA1 mRNA platform that significantly improves glucocerebrosidase (GCase) expression, stability, and lysosomal targeting. These advances support mRNA-LNP therapy as a compelling alternative to enzyme replacement for Gaucher disease, with broad implications for lysosomal storage disorder research.

• Ionomycin Calcium Salt: Precision Calcium Ionophore for Cell

  2026-06-03

  Ionomycin calcium salt empowers researchers to precisely modulate intracellular Ca2+ dynamics, enabling robust apoptosis induction and cancer cell growth inhibition. This article details optimized experimental workflows, troubleshooting methods, and practical insights for leveraging this calcium ionophore in advanced cell signaling and oncology studies.

406 records 12/28 page Previous Next First page 上5页 1112131415 下5页 Last page